Lobeglitazone, a novel thiazolidinedione, for secondary prevention in patients with ischemic stroke: a nationwide nested case-control study

INTRODUCTION: Ischemic stroke patients with diabetes are at high risk for recurrent stroke and cardiovascular complications. Pioglitazone, a type of thiazolidinedione, has been shown to reduce cardiovascular complications in patients with ischemic stroke and type 2 diabetes (T2D) or insulin resistan...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoo, Joonsang, Jeon, Jimin, Baik, Minyoul, Kim, Jinkwon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163714/
https://www.ncbi.nlm.nih.gov/pubmed/37147722
http://dx.doi.org/10.1186/s12933-023-01841-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163714/
https://www.ncbi.nlm.nih.gov/pubmed/37147722
http://dx.doi.org/10.1186/s12933-023-01841-4

Ejemplares similares